Market Trends Regenxbio stock up, Solid Bio down post Sarepta update (RGNX)By admin8996erT0allMarch 18, 2025 moxumbicRegenxbio (NASDAQ:RGNX) and Solid Biosciences (NASDAQ:SLDB) witnessed contrasting fortunes on Tuesday after Sarepta Therapeutics (NASDAQ:SRPT) disclosed a mortality linked to…
Market Trends Sarepta awarded $115.2M in Vyondys 53 patent case: reportBy admin8996erT0allDecember 21, 2024 Chris RyanA federal jury in Delaware has reportedly found that Japan’s Nippon Shinyaku infringed upon Sarepta’s (NASDAQ:SRPT) patent for its…
